British patients are preparing for a technological leap as Elon Musk’s Neuralink begins its maiden clinical trials in the United Kingdom. With approvals from UK medical regulators now secured, the
British patients are preparing for a technological leap as Elon Musk’s Neuralink begins its maiden clinical trials in the United Kingdom. With approvals from UK medical regulators now secured, the
Labour’s ambitious plans to modernise the National Health Service will see patients directed to consult an artificial intelligence-driven ‘AI GP’ as their primary healthcare contact point. The groundbreaking initiative, unveiled
Smith & Nephew, one of the world’s oldest and largest medical technology firms, has indicated it may consider a major structural overhaul of its orthopaedics division following years of sluggish






